Skyla A. Duncan

Interleukin-10 Conjugation to Carboxylated PVP-Coated Silver Nanoparticles for Improved Stability and Therapeutic Efficacy

Dieudonné R. Baganizi, Elijah Nyairo, Skyla A. Duncan et al. · Nanomaterials · 2017 · 103 citations · Full text

Pharmacy, Immunology, Pharmaceutics +17

Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells

Saurabh Dixit, Rajnish Sahu, Richa Verma et al. · Biomaterials · 2017 · 40 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Prolonged Release and Functionality of Interleukin-10 Encapsulated within PLA-PEG Nanoparticles

Skyla A. Duncan, Saurabh Dixit, Rajnish Sahu et al. · Nanomaterials · 2019 · 34 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

A nanovaccine formulation of Chlamydia recombinant MOMP encapsulated in PLGA 85:15 nanoparticles augments CD4+ effector (CD44high CD62Llow) and memory (CD44high CD62Lhigh) T-cells in immunized mice

Rajnish Sahu, Saurabh Dixit, Richa Verma et al. · Nanomedicine Nanotechnology Biology and Medicine · 2020 · 28 citations · Full text

Pharmacy, Immunology, Pharmaceutics +17

Suppressors of Cytokine Signaling (SOCS)1 and SOCS3 Proteins Are Mediators of Interleukin-10 Modulation of Inflammatory Responses Induced by<i>Chlamydia muridarum</i>and Its Major Outer Membrane Protein (MOMP) in Mouse J774 Macrophages

Skyla A. Duncan, Rajnish Sahu, Saurabh Dixit et al. · Mediators of Inflammation · 2020 · 20 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17